Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $14.31 USD
Change Today +0.10 / 0.70%
Volume 49.9K
LNDC On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

landec corp (LNDC) Snapshot

Open
$14.22
Previous Close
$14.21
Day High
$14.34
Day Low
$14.18
52 Week High
04/15/15 - $15.16
52 Week Low
10/9/14 - $10.75
Market Cap
385.6M
Average Volume 10 Days
59.3K
EPS TTM
$0.54
Shares Outstanding
26.9M
EX-Date
--
P/E TM
26.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for LANDEC CORP (LNDC)

Related News

No related news articles were found.

landec corp (LNDC) Related Businessweek News

No Related Businessweek News Found

landec corp (LNDC) Details

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and markets differentiated products in food and biomedical materials markets. It operates through three segments: Food Products Technology, Food Export, and Hyaluronan-Based Biomaterials. The Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruits, and vegetables utilizing the BreatheWay specialty packaging technology for the retail grocery, club store, and food services industry under the EatSmart and GreenLine brand names, as well as sells BreatheWay packaging to partners for non-vegetable products. The Food Export segment purchases and sells whole commodity fruit and vegetable products primarily to Asian markets and in the United States. The Hyaluronan-Based Biomaterials segment sells products utilizing hyaluronan (HA), a naturally occurring polysaccharide that is distributed in the extracellar matrix of connective tissues in animals and humans for medical use primarily in the ophthalmic, orthopedic, and veterinary markets, as well as supplies HA to customers pursuing other medical applications, including aesthetic surgery, medical device coatings, tissue engineering, and pharmaceuticals. This segment also operates as a contract development and manufacturing organization, which specializes in aseptic filling services. The company also licenses Intellicoat seed coatings to the farming industry; and Intelimer polymers for personal care products and other industrial products. Landec Corporation sells its products in the United States, Canada, Taiwan, Belgium, Japan, Indonesia, China, and other countries. The company was founded in 1986 and is headquartered in Menlo Park, California.

531 Employees
Last Reported Date: 08/1/14
Founded in 1986

landec corp (LNDC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $450.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $310.0K
Chief Operating Officer
Total Annual Compensation: $285.0K
Vice President, Chief Executive Officer of Ap...
Total Annual Compensation: $330.0K
Vice President and President of Lifecore Biom...
Total Annual Compensation: $259.2K
Compensation as of Fiscal Year 2014.

landec corp (LNDC) Key Developments

Landec Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 1, 2015; Provides Earnings Guidance for the Fourth Quarter of Fiscal Year 2015

Landec Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended March 1, 2015. For the quarter, the company reported product sales of $138,530,000 against $126,379,000 a year ago, driven primarily from the 90% growth in sales of Eat Smart superfood products at Apio Inc., food business. Operating income was $4,832,000 against $9,732,000 a year ago. Overall operating income was negatively impacted by expected lower sales of higher margin fermentation products at Lifecore Inc. decrease in operating income at Lifecore partially offset by a 44% increase in operating income at Apio. Net income before taxes was $6,127,000 against $10,101,000 a year ago. Net income available to common stockholders was $3,772,000 against $6,400,000 a year ago, primarily due to the expected $5.6 million decrease in operating income at Lifecore. Net income was further reduced by a $793,000, or $0.03 per share, due to a non-cash write off of the company’s equity ownership in Aesthetic Sciences as a result of Landec receiving updated information that led management to believe the investment was fully impaired. Diluted net income per share was $0.14 against $0.24 a year ago. Increases in cash included generating $13.4 million in cash flow from operations. For the nine months, the company reported product sales of $404,809,000 against $355,884,000 a year ago. The increase was primarily due to a 21%, or $54.6 million, increase in revenues from Apio’s value-added business and from a 3%, or $1.8 million, increase in revenues in Apio’s export business. These increases were partially offset by a 20%, or $7.6 million, expected decrease in Lifecore’s revenues compared to the same period last year. Operating income was $12,257,000 against $14,884,000 a year ago. Net income before taxes was $14,883,000 against $22,754,000 a year ago. Net income available to common stockholders was $9,348,000 against $14,603,000 a year ago. Diluted net income per share was $0.34 against $0.54 a year ago. The decrease was primarily due to: a $7.6 million decrease in operating income at Lifecore, a $4.6 million decrease in the change in the fair market value of the company’s Windset investment to a $3.5 million increase from a $8.1 million increase in the same period last year, and a $793,000 write off of the company’s investment in Aesthetic Sciences. These decreases in net income were partially offset by: a 46%, or $4.9 million, increase in operating income at Apio and a $2.6 million decrease in the income tax expense. Capital expenditures primarily for capacity expansion were $10.2 million. For the fourth quarter of fiscal 2015, the company expects revenue is to be in the range of $130.0 million to $135.0 million and diluted earnings per share to be $0.18 to $0.20.

Landec Corp. to Report Q3, 2015 Results on Mar 31, 2015

Landec Corp. announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Mar 31, 2015

Landec Corp., Q3 2015 Earnings Call, Apr 01, 2015

Landec Corp., Q3 2015 Earnings Call, Apr 01, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LNDC:US $14.31 USD +0.10

LNDC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LNDC.
View Industry Companies
 

Industry Analysis

LNDC

Industry Average

Valuation LNDC Industry Range
Price/Earnings 28.1x
Price/Sales 0.7x
Price/Book 1.8x
Price/Cash Flow 27.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANDEC CORP, please visit www.landec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.